Bank of America Corp DE Increases Stake in Delcath Systems, Inc. (NASDAQ:DCTH)

Bank of America Corp DE increased its holdings in Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) by 1,816.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 25,700 shares of the company's stock after purchasing an additional 24,359 shares during the period. Bank of America Corp DE owned approximately 0.08% of Delcath Systems worth $309,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the business. Apis Capital Advisors LLC bought a new stake in Delcath Systems in the fourth quarter worth $1,618,000. 683 Capital Management LLC bought a new stake in Delcath Systems in the fourth quarter worth $741,000. Jane Street Group LLC increased its position in Delcath Systems by 1,364.6% in the fourth quarter. Jane Street Group LLC now owns 178,797 shares of the company's stock worth $2,153,000 after purchasing an additional 166,589 shares during the last quarter. Schonfeld Strategic Advisors LLC bought a new stake in Delcath Systems in the fourth quarter worth $605,000. Finally, Northern Trust Corp increased its position in Delcath Systems by 57.5% in the fourth quarter. Northern Trust Corp now owns 100,356 shares of the company's stock worth $1,208,000 after purchasing an additional 36,643 shares during the last quarter. Institutional investors own 61.12% of the company's stock.

Analyst Ratings Changes

DCTH has been the subject of a number of recent analyst reports. HC Wainwright reissued a "buy" rating and set a $29.00 target price (up from $24.00) on shares of Delcath Systems in a research note on Friday, May 23rd. Wall Street Zen lowered shares of Delcath Systems from a "strong-buy" rating to a "buy" rating in a research report on Sunday, June 1st. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $24.00.

Delcath Systems Price Performance

NASDAQ:DCTH traded down $0.30 during midday trading on Friday, hitting $15.34. The company's stock had a trading volume of 316,414 shares, compared to its average volume of 387,687. Delcath Systems, Inc. has a fifty-two week low of $7.17 and a fifty-two week high of $18.23. The firm's 50 day moving average is $14.07 and its 200-day moving average is $13.60. The firm has a market cap of $534.23 million, a P/E ratio of -11.36 and a beta of 0.95.

Delcath Systems (NASDAQ:DCTH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.07). The business had revenue of $19.80 million during the quarter, compared to analyst estimates of $16.83 million. Delcath Systems had a negative return on equity of 338.16% and a negative net margin of 150.70%. As a group, analysts forecast that Delcath Systems, Inc. will post -0.79 EPS for the current year.

Delcath Systems Company Profile

Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.